News

Clark County strives to capitalize on surging life sciences industry

By Troy Brynelson, Columbian staff writer The Columbian (Original Article) Jonathan DeHart had hoped to land his company, a fledgling manufacturer of gene sequencing devices borne out of incubators at Intel, in the Portland-Vancouver metropolitan area. Then they found a glitch. The kind of space that they were looking for, called wet lab space, wasn’t very abundant here. As a young company still raising its early funds, they had to find space to rent. Building their own space was a nonstarter. “When you’re young and early, you’ve got to put your capital toward tech development,” he said. “You can’t be spending $300,000 to a $1 million just to build a space to start working.” Northshore Bio, as it would eventually be called, made a compromise: locate its administrative offices in Camas, near the robust research scene revolving around Oregon Health & Science University, and its wet lab space in Seattle. It’s one company’s story, but it offers a glimpse into some directions Clark County has to take to reach its goal of becoming a hotbed for life sciences firms. Seattle has a road map: a powerhouse research institution in its backyard, capital investors, and it is loaded with lab space and [...]

Clark County strives to capitalize on surging life sciences industry 2018-01-17T11:08:55+00:00

Oregon scientist develops promising vaccine against tuberculosis

Lynne Terry, lterry@oregonian.com The Oregonian/OregonLive An Oregon scientist has developed a vaccine against tuberculosis that appears to be highly effective against the devastating disease. The vaccine reduced tuberculosis infections by 70 percent in rhesus monkeys, according to a paper published Monday in the journal Nature Medicine. Tuberculosis doesn't always make people sick, but it almost always causes severe disease in rhesus monkeys, said Dr. Louis Picker, who developed the vaccine at Oregon Health & Science University. Though the vaccine has only been given to rhesus macaques, it will eventually be tested in people, Picker said. His findings offer hope for a disease that sickened more than 10 million people across the globe in 2016, according to the federal Centers for Disease Control and Prevention. Every year, about 2 million die from TB, which affects the lungs but also can attack the kidneys, spine or brain. "TB is actually the biggest infectious killer now – it's surpassed HIV," Picker said. "It's amazing to me that we haven't seen more of it in this country." A century ago, TB was a leading cause of death in the United States and Europe. Antibiotics and cleaner living conditions helped stem cases. In 2016, more than 9,000 people were [...]

Oregon scientist develops promising vaccine against tuberculosis 2018-01-17T11:05:37+00:00

How a Eugene startup is using worms to spark medical breakthroughs

By Elizabeth Hayes  –  Staff Reporter, Portland Business Journal Jan 11, 2018, 10:56am Most of us don’t give the lowly worm much thought during the course of our day, unless we’re digging in our garden. For Eugene-based NemaMetrix, the C. elegans nematode worm is the key to finding a cure for a host of human genetic diseases. NemaMetrix sells a drug discovery platform that allows scientists to quickly assess if a drug has therapeutic value or potentially dangerous side effects. The startup’s ScreenChip System collects data after DNA from a human patient is injected into these simple microscopic animals, which provide a living proxy to watch disease progression or drug reactions quickly and cheaply. CEO Matt Beaudet believes NemaMetrix has hit on the biggest advancement in drug discovery in decades. “Honestly, I believe we’re building a platform that will transform access to living animals for basic research and applied research, figuring out what it means for humans,” Beaudet said. “I don’t think there’s a limit to the number of labs we can get in.” Read the rest of the article at Portland Business Journal.

How a Eugene startup is using worms to spark medical breakthroughs 2018-01-12T10:04:36+00:00

Calling All Startups! Apply by this Friday, January 12 for PitchfestNW.

PitchfestNW, a startup conference and competition within TechfestNW, the Upper Left Coast's largest annual tech event, is accepting applications for 2018. TechfestNW — now in its 7th year — is a gathering of innovators, startups, entrepreneurs, tech companies and investors from around the globe that takes place in Portland, OR. Why? There is no cost to apply, and accepted startups receive an all-access ticket to TechfestNW, inclusion in the pitch competition to a panel of investors and industry leaders, and networking opportunities. There will also be an option to upgrade to PitchfestNW Amplified to further showcase your company. Learn more about PitchfestNW here, and apply by January 12.  About TechfestNW: April 5-6, 2018 During the day, TechfestNW offers compelling speakers, a startup pitch competition, workshops and companies showcasing the latest tech. At night, TechfestNW offers parties, networking and an opportunity to explore one of the greatest cities in the country. In case you missed it - last year, the winner of TechFestNW was Madorra Medical, a medical device company out of the Oregon Bioscience Incubator (OBI). Read more at Willamette Week: The Best Startup Pitch in Town? A Portland-Based Company That Soothes the Symptoms of Menopause. Madorra was selected from 74 [...]

Calling All Startups! Apply by this Friday, January 12 for PitchfestNW. 2018-01-08T10:06:52+00:00

Leading Organizations in the Pacific Northwest Sign MOU for Cascadia Venture Acceleration Network, a Partnership to Fuel Innovation

New partnership among British Columbia, Washington and Oregon boosts innovation by introducing startups to cross-border funding and collaboration opportunities SEATTLE, Dec 8, 2017 – Today, nearly 50 organizations in the Pacific Northwest convened at Cambia Grove in Seattle to sign a memorandum of understanding (MOU) establishing the Cascadia Venture Acceleration Network, a partnership of incubators, accelerators, universities, investors and industry associations that have pledged to work collaboratively in support of entrepreneurs and researchers across British Columbia, Washington state and Oregon. The Cascadia Venture Acceleration Network will initially focus on the Life Sciences, Information Technology, and CleanTech industries, then expand to include other sectors in the future. “In line with the Government of Canada’s mandate to foster international partnerships in science, technology and innovation, the Consulate General of Canada in Seattle led the development of the Cascadia Venture Acceleration Network as a springboard from which to launch new strategic and regionally-focused initiatives targeted at entrepreneurs, innovators, and academic researchers in the Pacific Northwest,” said Lewis Coughlin, Consul and Trade Commissioner, Consulate General of Canada in Seattle. The Cascadia Venture Acceleration Network MOU does not replace, but rather fully supports the innovation partnership that began in September 2016, when the State of [...]

Leading Organizations in the Pacific Northwest Sign MOU for Cascadia Venture Acceleration Network, a Partnership to Fuel Innovation 2017-12-11T16:34:07+00:00

Two Winners Announced from Nine Startups and Ten Research Innovators at Oregon Bioscience Showcase 2017

FOR IMMEDIATE RELEASE – November 21, 2017 TWO WINNERS ANNOUNCED FROM NINE STARTUPS AND TEN RESEARCH INNOVATORS AT OREGON BIOSCIENCE SHOWCASE 2017 Young researcher and entrepreneurial medical device company take top honors  CONTACT: Dianne Danowski Smith, Board member, (503) 201-7019, @OregonBio  (Portland, Ore.) – With just three minutes each, ten high school and academic researchers had three minutes to ‘fast pitch’ their projects to the 300+ bioscience professionals in the audience at the Oct. 30, 2017 Oregon Bioscience Showcase. It was their unique opportunity to discuss their emerging research and its impact in the local and global bioscience ecosystem. In a true homage to the next generation of emerging great minds, Camas, Washington high school student, 11th grader Monica Chang, won the overall Research Fast Pitch with her project entitled, “A Closer Look at Memory: The Effect of Diurnal Rhythms on Perineuronal Nets.” Chang competed against three other high schoolers, one company founder and five academic researchers. “Our Research Fast Pitch event was a phenomenal; it allowed our research community to not only convey their cutting-edge research findings, it offered them an opportunity to tell their stories. Each participant crafted a story arc that brought together not only research, but [...]

Two Winners Announced from Nine Startups and Ten Research Innovators at Oregon Bioscience Showcase 2017 2017-11-28T09:54:41+00:00

Nine Startups and Ten Researchers Share Their Innovations at Oregon Bioscience Showcase 2017

FOR IMMEDIATE RELEASE – Oct. 24, 2017 NINE STARTUPS AND TEN RESEARCHERS SHARE THEIR INNOVATIONS AT OREGON BIOSCIENCE SHOWCASE 2017 Oregon Governor Kate Brown  (@OregonGovBrown) will provide opening comments to highlight the entrepreneurs’ event #OregonBio2017  CONTACT: Denise McCarty, Executive Director, (503) 548-4432 Dianne Danowski Smith, Board member, (503) 201-7019, @OregonBio (Portland, Ore.) -- Nine emerging device, diagnostic and digital health startups will get just 10 minutes to highlight their companies at Oregon Bioscience Showcase 2017’s 6th Annual Company Pitch Showcase on Monday, Oct. 30 at 1 p.m. in OMSI’s Empirical Theater. To kick off the event, Governor Kate Brown will welcome the next generation of researchers and startups. Hundreds of attendees will get the direct line on formative concepts from these startups such as how artificial intelligence is being used to extract biological information; how wearable technologies will precisely track patients’ responses to interventions; how to help developing countries diagnose and manage parasites that cause such diseases as malaria; and how a USB-drive-sized device with a humanized microscopic animal represents an individual patient’s version of a disease, among other technologies. Oregon Bio worked closely with the State of Oregon’s bioscience Signature Research Center, OTRADI (Oregon Translational Research and Development Institute) to [...]

Nine Startups and Ten Researchers Share Their Innovations at Oregon Bioscience Showcase 2017 2017-10-24T16:12:06+00:00

Governor Kate Brown to Launch Bio Researchers’ and Entrepreneurs’ Sessions at the Oregon Bioscience Showcase

FOR IMMEDIATE RELEASE – Oct. 17, 2017 GOVERNOR KATE BROWN TO LAUNCH BIO RESEARCHERS’ AND ENTREPRENEURS’ SESSIONS AT THE OREGON BIOSCIENCE SHOWCASE The first-ever appearance by an Oregon Governor at the entrepreneurs’ event will highlight the researchers’ fast pitch and the company showcase #OregonBio2017 CONTACT: Denise McCarty, Executive Director, (503) 548-4432 Dianne Danowski Smith, Board member, (503) 201-7019, @OregonBio (Portland, Ore.)  - Attendees at the Oregon Bioscience Showcase will hear from Governor Kate Brown (@OregonGovBrown) as she launches the high-profile event with opening remarks and welcomes the next generation of researchers and start-up companies. The Oregon Bioscience Showcase 2017 will take place on Oct. 30 at 1 p.m. in OMSI’s Empirical Theater. With just three minutes each, ten high school and academic researchers will compete, presenting their projects to the 200+ bioscience professionals in the audience. This is their unique opportunity to discuss their emerging research and its impact in the local and global bioscience ecosystem. Here’s who they are and their focus: Cynthia Bui, 12th Grade, Madison High School, Portland A Genetic Approach to Designing a Novel Biological Sensor to Monitor Water Contamination Monica Chang, 11th Grade, Camas High School, Camas, Washington A Closer Look at Memory: The Effect [...]

Governor Kate Brown to Launch Bio Researchers’ and Entrepreneurs’ Sessions at the Oregon Bioscience Showcase 2017-10-17T10:00:02+00:00

Portland-Based Immuno-oncologist Dr. Bernard A. Fox To Present at Siena, Italy Conference

October 7, 2017 FOR IMMEDIATE RELEASE Contact: Patricia Pearson, ppearson@ubivac.com Siena, Italy—Dr. Bernard A. Fox, internationally known expert in immuno-oncology will meet with other cancer experts here Saturday to discuss recent advances in treatmentsthat hold promise for improved treatments and increased survival for patients with cancer. Dr. Fox, chief executive officer, UbiVac, www.ubivac.com, will discuss the latest research in agonistic antibodies in an era of antagonistic antibodies. He will provide insights into mono-therapy, as well as combination and/or sequential therapies from his latest publication on the topic and UbiVac’s evaluation of patients enrolled on their phase II clinical trial for NSCLC. The event, “A Vision of Immuno-Oncology: The Siena Consensus,” will be held October 7, 3 to 6 pm, as a “think tank” of those involved in developing the latest cancer immunotherapies. It is sponsored by the Network Italiano per la Bioterapia del Tumori/The Italian Network for Cancer Biotherapy (NIBIT), is part of its XVth Cancer Bio-Immunotherapy Meeting. A non-profit foundation, NIBIT was formed in 2004 and is focused on bringing together groups involved in clinical and pre-clinical research in cancer immunotherapy and biotherapy to discuss the latest advances in the field. This meeting seeks to help build consensus among [...]

Portland-Based Immuno-oncologist Dr. Bernard A. Fox To Present at Siena, Italy Conference 2017-10-13T10:22:37+00:00

Oregon’s Life Science Industry on Display: Oregon Bioscience Showcase 2017

The first-ever Oregon Bioscience Showcase, on October 30, combines the Research Fast Pitch and Company Pitch Showcase, presenting emerging companies and rising-star researchers #OregonBio2017 CONTACT: Denise McCarty, Executive Director, (503) 548-4432 Dianne Danowski Smith, Board member, (503) 201-7019, @OregonBio (Portland, Ore.)  - Three minutes. That’s all the time nine local researchers and students will have to showcase their research and projects to a room full of bioscience professionals, enthusiasts and judges. This is their unique opportunity to discuss their emerging research and its impact in the local and global bioscience ecosystem. But before the selected researchers take center stage, nine emerging companies in various funding cycles in the device, diagnostics, and digital health sectors will get a mere 10 minutes to unveil their secret sauce to the audience as part of the 6th annual Company Pitch Showcase. Judges and the audience will have an opportunity to ask questions after their pitch as well as meet the entrepreneurs between pitch sessions. Company executives, entrepreneurs; investors; business, economic development and life science professionals; researchers; vendors; and STEM students are all invited to the Oregon Bioscience Showcase 2017 on Oct. 30, from 1 to 6 p.m. at OMSI’s Empirical Theater. The Showcase event [...]

Oregon’s Life Science Industry on Display: Oregon Bioscience Showcase 2017 2017-09-22T09:25:36+00:00